Scoop has an Ethical Paywall
Recall of 2 batches of GlucaGen® HypoKit
Novo Nordisk Ltd is recalling 2 batches of GlucaGen® HypoKit in New Zealand.
Auckland, New Zealand, Thursday 8th September 2016
Novo Nordisk Pharmaceuticals Limited is recalling 2 batches of GlucaGen® HypoKit in New Zealand. The GlucaGen® HypoKit is indicated for the ‘treatment of severe hypoglycaemic reactions (low blood sugar) which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents’.
Novo Nordisk conducted an investigation showing a small number (0.006%) of needles were detached from the pre-filled syringe supplied in certain batches of GlucaGen® HypoKit. To protect patient safety Novo Nordisk is recalling affected batches from wholesalers, pharmacies and patients in New Zealand.
The recalled GlucaGen® HypoKit batch numbers and
expiry dates are:
Batch No: FS6X537, Expiry:
31-Aug-2017
Batch No: FS6X873, Expiry:
31-Aug-2017
ends
NZ Psychological Society: Remembering The Past Guides Our Future 
New Zealand Olympic Committee: Motherhood In Focus For Wāhine Toa Graduates Ahead Of Mother's Day
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau